最新报道:According to the news from Bijie.com, MEI Pharma announced the completion of a $100 million private placement financing, selling 29,239,767 common shares or equivalent prepaid warrants at a price of $3.42 per share. The proceeds will be used to establish a Litecoin strategic reserve. The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private placement, to join the board of directors, and appointed GSR as its digital asset and fund management consultant to oversee the implementation of the Litecoin reserve strategy. (Businesswire)